Due to the growing interest of International Atomic Energy Agency (IAEA) Member States in implementing targeted radionuclide therapy (TRT) in general, the demand for alpha-emitting radionuclides and radiopharmaceuticals is enormous. As an international platform for peaceful applications of radionuclides, the IAEA has been implementing several activities focusing on the production and quality control of alpha emitters and radiopharmaceuticals as well as capacity building in the field, through Technical Meetings, Workshops, Publications and Conference Supports, IAEA-Coordinated Research Projects (CRP) and Technical Cooperation Program (TC). This review article summarises the IAEA activities on the production and quality control of alpha emitter radiopharmaceuticals for targeted alpha therapy (TAT) and a roadmap to future steps including but not limited to the ongoing CRP on 225Ac-radiopharmaceuticals
JALILIAN Amirezza;
KLEYNHANS Janke;
BOUZIOTIS Penelope;
BRUCHERTSEIFER Frank;
CHAKRABORTY S.;
DE BLOIS Erik;
DENECKE Melissa;
ELBOGA U;
GIZAWY M;
HORAK C;
JANG J;
KORDE Aruna;
MAJKOWSKA PILIP Agnieszka;
MDLOPHANE Amanda;
OCAMPO-GARCIA B;
SELIVANOVA S.V.;
STAROVOITOVA Valeriia;
WOJDOWSKA W;
ZEEVART Jan;
RADCHENKO Valery;
2025-11-28
ELSEVIER SCIENCE INC
JRC144851
1872-9614 (online),
https://doi.org/10.1016/j.nucmedbio.2025.109008,
https://publications.jrc.ec.europa.eu/repository/handle/JRC144851,
10.1016/j.nucmedbio.2025.109008 (online),
| Name | Country | City | Type |
|---|
This document is only visible at the Commission level.
You are not authorized to publish or distribute it outside the European Commission.
This is a public document. You can share this publication.
Datasets
| ID | Title | Public URL |
|---|
Dataset collections
| ID | Acronym | Title | Public URL |
|---|
Scripts / source codes
| Description | Public URL |
|---|
Additional supporting files
| File name | Description | File type |
|---|